Domača stranP1RG34 • BVMF
add
Perrigo Co Plc Bdr
Prejšnji trg. dan.
146,55 R$
Letni razpon
135,91 R$ - 150,33 R$
Tržna kapitalizacija
3,47 mrd. USD
Borzne novice
Finančni podatki
Izkaz poslovnega izida
Prihodek
Čisti dohodek
(USD) | dec. 2024info | Sprememba L/L |
---|---|---|
Prihodek | 1,14 mrd. | −1,61 % |
Stroški poslovanja | 117,10 mio. | −64,85 % |
Čisti dohodek | −44,50 mio. | −37,77 % |
Čista dobičkovnost prihodkov | −3,91 | −40,14 % |
Earnings per share | 0,93 | 8,14 % |
EBITDA | 349,10 mio. | 93,84 % |
Efektivna davčna stopnja | 159,29 % | — |
Bilanca stanja
Skupna sredstva
Skupne obveznosti
(USD) | dec. 2024info | Sprememba L/L |
---|---|---|
Denar. in kratkor. naložbe | 558,80 mio. | −24,93 % |
Skupna sredstva | 9,65 mrd. | −10,74 % |
Skupne obveznosti | 5,33 mrd. | −11,80 % |
Celoten lastniški kapital | 4,32 mrd. | — |
Shares outstanding | 136,46 mio. | — |
Razmerje P/B | 4,63 | — |
Donosnost sredstev | 6,45 % | — |
Donosnost kapitala | 7,59 % | — |
Denarni tok
Neto sprememba denarnih sredstev
(USD) | dec. 2024info | Sprememba L/L |
---|---|---|
Čisti dohodek | −44,50 mio. | −37,77 % |
Denar iz dejavnosti | 312,60 mio. | 49,78 % |
Denar iz naložb | −37,10 mio. | −62,72 % |
Denar iz financiranja | −1,15 mrd. | −2.487,67 % |
Neto sprememba denarnih sredstev | −904,70 mio. | −691,31 % |
Prost denarni tok | 517,39 mio. | 45,97 % |
Vizitka
Perrigo Company plc is an American Irish-registered manufacturer of private label over-the-counter pharmaceuticals, and while 70% of Perrigo's net sales are from the U.S. healthcare system, Perrigo is legally headquartered in Ireland for tax purposes, which accounts for 0.60% of net sales. In 2013, Perrigo completed the sixth-largest US corporate tax inversion in history when it reregistered its tax status to Ireland to avoid U.S. corporate taxes. Perrigo maintains its corporate headquarters in Grand Rapids, Michigan, within Michigan State University's Grand Rapids Innovation Park.
Perrigo engages in the acquisition, manufacture, and sale of consumer healthcare products, generic prescription drugs, and active pharmaceutical ingredients, primarily in the United States, from its base in Ireland. On 21 December 2018, Perrigo suffered its biggest one-day share price fall in its history after the Irish Revenue Commissioners issued a tax claim against Perrigo that equated to half of its market value. Wikipedia
Generalni direktor
Datum ustanovitve
1887
Spletno mesto
Zaposleni
8.379